Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dexamethasone therapy in bacterial meningitis

H S Jafari1, G H McCracken

  • 1Department of Pediatrics, University of Texas Southwestern Medical School, Dallas 75235-9063.

Pediatric Annals
|February 1, 1994
PubMed
Summary

Dexamethasone reduces tissue damage in bacterial meningitis by targeting inflammation. Early administration with antibiotics improves neurological outcomes in children, but delayed treatment is ineffective.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Surveillance during an era of rapidly changing poliovirus epidemiology in India: the role of one vs. two stool specimens in poliovirus detection, 2000-2010.

Epidemiology and infection·2013
Same author

Anterior poliomyelitis; from a patient's point of view.

Physiotherapy·2010
Same author

Tigecycline therapy significantly reduces the concentrations of inflammatory pulmonary cytokines and chemokines in a murine model of Mycoplasma pneumoniae pneumonia.

Antimicrobial agents and chemotherapy·2009
Same author

Respiratory tract infection with Mycoplasma pneumoniae in interleukin-12 knockout mice results in improved bacterial clearance and reduced pulmonary inflammation.

Infection and immunity·2006
Same author

Factors influencing the anti-inflammatory effect of dexamethasone therapy in experimental pneumococcal meningitis.

The Journal of antimicrobial chemotherapy·2003
Same author

Pharmacodynamics and bactericidal activity of moxifloxacin in experimental Escherichia coli meningitis.

Antimicrobial agents and chemotherapy·2001

Area of Science:

  • Pediatric Infectious Diseases
  • Neuroinflammation
  • Pharmacology

Background:

  • Bacterial meningitis involves a harmful inflammatory cascade.
  • Dexamethasone can mitigate tissue injury by modulating inflammatory mediators.

Purpose of the Study:

  • To evaluate the efficacy of dexamethasone in treating bacterial meningitis.
  • To determine optimal timing for dexamethasone administration in pediatric patients.

Main Methods:

  • Review of pathophysiological understanding of bacterial meningitis.
  • Analysis of dexamethasone's role in inhibiting inflammatory processes.
  • Assessment of treatment timing relative to antibiotic administration.

Main Results:

  • Dexamethasone attenuates tissue injury by inhibiting host inflammatory mediators.
  • Early dexamethasone administration (with or before first antibiotics) improves neurological outcomes.
  • Late dexamethasone administration (12-24 hours after antibiotics) shows no benefit.

Conclusions:

  • Dexamethasone is recommended for infants and children with bacterial meningitis when given early with antibiotics.
  • Optimal timing is critical for beneficial effects; delayed use is unlikely to help.
  • Improved neurological outcomes support early dexamethasone use in specific bacterial meningitis cases.

Related Experiment Videos